Category: Top 200 Lawyer Plus - 2024

Phillips Lytle is a longstanding firm of over 170 attorneys with offices across New York State as well as in Chicago, Washington DC, and Canada.  Lisa co-leads Phillips Lytle’s Psychedelics and Mental Health Therapeutics practice, assisting clients in the psychedelics and ketamine space (including ketamine-assisted psychotherapy) to accomplish their business…

Robert Rush is an experienced attorney with a passion for advocating for change in the fields of psychedelics and plant medicine law. With 19 years of legal experience, he has dedicated his current practice to fighting for the rights of individuals and organizations involved in these emerging and transformative industries….

With a passion for organizational growth, Hilary advises clients in the cannabis, healthcare, and life sciences spaces on transactions, regulatory compliance, governance matters, and other corporate needs. Hilary likes being a dealmaker: she values building collegial relationships with clients and other attorneys, and she loves helping clients create value and…

AD LUCEM LAW CORPORATION was established in 2013 by Robert W.E. Laurie, an award-winning international lawyer with qualifications from England and admission to the British Columbia Bar. Robert's legal practice is centered on various aspects of commercial business, governmental affairs, regulatory matters, as well as charter and constitutional issues related…

Joshua S. Bauchner serves as the chair of the Cannabis and Psychedelics Practice Group and is a Partner in the Litigation and Bankruptcy practice groups. He brings a depth of expertise and dedication to the practice, where he is involved in complex commercial and securities litigation, class actions, and bankruptcy-related…

As General Counsel to Numinus Wellness Inc., and formerly General Counsel to Field Trip Health Ltd., and Reunion Neuroscience Inc., Paula’s career in the development and delivery of legal psychedelic treatments includes advising private start-ups, TSX-listed and NASDAQ-listed issuer clients. Prior to working in psychedelics, Paula held various executive roles…

Curt has developed a national healthcare practice providing transactional, regulatory and compliance guidance for hospitals, physicians and other types of healthcare providers. Curt routinely serves as outside counsel to hospitals and health systems regarding complex hospital/physician integration arrangements. He also is experienced in handling compliance and reimbursement matters, including government…

A co-founder and co-leader of the firm’s Psychedelics and Emerging Therapies Practice Group, Natasha advises clients on the regulatory matters inherent in new drug development. She also advises behavioral health clients on compliance matters. Natasha approaches her practice with great passion for the promise of psychedelics and other new drugs….

Kimberly is a leading member of the psychedelic law practice group at Husch Blackwell. As a former research scientist for biotech startups, Kimberly has a unique perspective in the emerging area of psychedelic therapeutics. She keeps current on the academic and commercial research and drug discovery efforts in this rapidly…